Ewing sarcoma (EwS), a highly aggressive malignancy affecting children and young adults, is primarily driven by a distinctive oncogenic fusion, the EWSR1‐ETS, whose activity is a key source of epigenetic and clinical heterogeneity. Here, EWSR1 is linked to Ewing sarcoma.